T he incidence of type 1 diabetes in youth under 20 years of age is increasing worldwide (1) . Recently, we reported an annual average increase of 2.3% in youth 0 -17 years of age in Colorado, with the greatest increase reported in children under 5 years of age (2) . Trends of such magnitude and consistency can only be explained by changes in environmental risk factors (3) . Recent hypotheses argue that an increased environmental pressure associated with type 1 diabetes risk may reduce the need for a strong background of genetic susceptibility in order for type 1 diabetes to develop.
Type 1 diabetes has a genetic component that is neither sufficient nor necessary, in terms of current known determinants. HLA class II region polymorphisms alone explain 40 -50% of familial clustering in type 1 diabetes risk (4) . There is an approximate 5-fold increase in risk of type 1 diabetes for the homozygous expression of either DRB1*03 or DRB1*04 and a 14-fold increased risk for those with heterozygous expression (DRB1*03/DRB1*04) (5) . Although the DRB1 and the DQA1 and DQB1 genes are important in determining susceptibility to type 1 diabetes, examining the penetrance of these genes has provided a better understanding of the involvement of environmental risk factors. Four studies (6 -9) To assess whether the sample of youth with available HLA typing was representative of the entire patient population of youth with type 1 diabetes diagnosed in these two time periods, demographic and clinical characteristics of study participants were compared with those of nonparticipants. Table 1 shows these characteristics according to time period and ethnicity. In 1978 -1988, there were no significant differences for either NHW or Hispanic youth. In 2002-2004, the only significant difference between those with and without HLA typing was a higher frequency of a positive family history of diabetes in NHW participants with typing available. However, no significant relationship was noted between having t h e h i g h e s t -r i s k H L A g e n o t y p e ( D R B 1 * 0 3 -D Q B 1 * 0 2 / D R B 1 * 0 4 -DQB1*03) and having a positive family history of diabetes in either time period (P ϭ 0.96). These data suggest that our samples of NHW and Hispanic youth with measured HLA are likely representative of the larger eligible population with type 1 diabetes in both periods, or that they differ in characteristics not strongly related with the frequency of high-risk HLA genotypes. Therefore, we believe that any observed trends or lack thereof in the frequency and distribution of HLA genotypes over time in our population are not likely to be due to selection bias. All participants provided informed consent and both the Colorado Type 1 Diabetes Registry and SEARCH were approved by relevant institutional review boards.
HLA typing DRB1 and DQB1 typing was performed using OneLambda PCR assays that were standard for the time period in which they were used (1978 -1988 and 2002-2004 ) (16) . The main difference between assays was the number of DQB1 alleles identified that had sequence-specific oligonucleotides (SSOs) available for typing. There were seven DQB1 SSOs identified for typing in 1978 -1988, and there were 100 DQB1 SSOs identified for typing in [2002] [2003] [2004] . Due to the difference in the number of DQB1 alleles identified and the availability of SSOs for typing these alleles over the two periods, only the gene locus was used in the analysis to compare genotypes (e.g., DQB1*02 vs. DQB1*0201). Additionally, the current PCR sequencespecific oligonucleotide probes used in 2002-2004 allowed for a larger number Data are % (n) and means Ϯ SD unless otherwise indicated.
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DIABETES CARE, VOLUME 31, NUMBER where X is not DRB1*04-DQB1*03, and DRB1*03-DQB1*02/unknown); and neutral risk (X/X or X/unknown). The X haplotype denotes all other haplotypes not defined above. The unknown haplotype denotes a haplotype that was unable to be typed.
Statistical analyses
Descriptive univariate analysis was used to determine the frequency of the genotypes for each period.
2 statistics were used to compare frequencies of HLA haplotypes by race and period and genotypes by high-risk (DRB1*03-DQB1*02/ DRB1*04-DQB1*03) versus all other genotypes. Multivariate logistic regression was used to adjust for potential confounders (onset age, sex, family history of diabetes, and race/ethnicity) and assess temporal trends. High-risk was compared with all other genotypes using all other genotypes as the referent group. SAS version 9.1 (20) was used for all analyses.
RESULTS -A total of 364 youth (100 in 1978 -1988, and 264 in 2002-2004) with new-onset type 1 diabetes at age 5-17 years had HLA genes measured as described above. (Table 3) , the most dramatic decreasing trend in the prevalence of the high-risk genotype occurred in those aged 5-9 years (51% [1978 -1988] vs. 32% [2002] [2003] [2004] , P ϭ 0.05) with a coincident increasing trend in the proportion with the DRB1*04-DQB1*03 (homo-or heterozygous) genotype in the same age-group (19% [1978 -1988] found in 5-to 9-year-olds, suggesting that environmental pressures may have a greater impact on type 1 diabetes risk at earlier ages. This is the first documentation of such a trend in a representative biracial sample of youth with type 1 diabetes in the U.S. Our study supports previous findings from Finland (9) and the U.K (8), both including Caucasian adults with childhood-onset type 1 diabetes diagnosed up to 80 years apart. The U.K. study showed that the frequency of the high-risk genotype was 12% lower in adults diagnosed up to 15 years of age in 1985-2002 compared with those diagnosed between 1922-1946 and 21% lower in those diagnosed under 5 years of age (8) . The Finnish study showed that the frequency of the high-risk genotype was 7.1% lower and that of protective genotypes was 7.2% higher in adults with childhood-onset type 1 diabetes diagnosed after 1990 compared with those diagnosed before 1965 (9) . Two older studies conducted in Finland in the 1980s reported a decrease in HLA-DR3 by 25% for those diagnosed with type 1 diabetes in the 1980s compared with those diagnosed in the 1960s (6,7). However, the major limitation of these studies was the potential for selection bias. Neither of these studies provided information on the size or representativeness of the referent population. More importantly, two studies (8, 9) measured HLA in adults who were diagnosed with type 1 diabetes as children in the first half of the 20th century, when early mortality associated with type 1 diabetes was high. Therefore, the frequency and distribution of HLA genotypes in this sample may be significantly influenced by factors associated with survival of type 1 diabetes. An underestimate of the proportional distribution of high-risk HLA genotypes in earlier time periods (due to a potential association of high-risk HLA genes with increased mortality) may have resulted in underestimating the true temporal trends in the proportion of type 1 diabetes cases with high-risk HLA genotypes in these earlier studies. In contrast, our study genotyped youth with type 1 diabetes relatively close to their disease onset and thus is not affected by survivor bias. In addition, we were able to provide evidence that the sample included in the analysis was representative of the Colorado population of youth with type 1 diabetes in both time periods.
Nevertheless, our study has several limitations. Importantly, although the same method was used for typing, due to the specific time periods in which they were performed, two slightly different assays were used, namely, OneLambda LabType Luminex SSO in 2002 and OneLambda SSO in 1978 -1988 . We were unable to validate the results obtained with the earlier SSO assay due to the lack of stored DNA samples and inability to recontact participants. However, previous studies (19, 21) suggest comparable agreement in serologic specificity with an 85% allele agreement. Due to this and the difference in the number of allele SSOs available for typing over time, only the gene locus was used in this analysis. By not using expanded allele information, we potentially introduced some misclassification, likely increasing the proportion with the high-risk genotype. However, misclassification would be similar for both time periods and therefore unlikely to influence our analysis of trends. Because for 2002-2004 we did have allele information on 100 DQB1 SSOs, we estimated the magnitude of the potential misclassification, and only four (1.5%) cases were misclassified as having the highest-risk genotype in 2002-2004 using the expanded allele information only. In addition, there were 12 youth from 1978 -1988 that did not have complete genotypes. These youth were included in the study and classified as haplotype unknown. This categorization could have led to some misclassification. Specifically, if the unknown haplotype was DRB1*03-DQB1*02 or DRB1*04-DQB1*03, youth would have been classified as high risk based on the typed haplotype or as heterozygous for the above haplotypes. For example, in the extreme situation where all youth with the unknown haplotype in the first time period would have been in fact at "highrisk," the proportion of youth with the There are several hypotheses proposed to explain the increase in type 1 diabetes incidence in youth and the earlier age at onset. The "accelerator" and "overload" hypotheses suggest that an increase in body mass in genetically susceptible individuals accelerates ␤-cell decline or stresses (overloads) the ␤-cells, leading to an early age at type 1 diabetes diagnosis (22, 23) . The "hygiene hypothesis" postulates that the decreasing early life exposure to infectious agents in Westernized societies has led to an impairment in the maturation of the immune system, thus permitting an increased occurrence of immune-mediated disorders, such as asthma and type 1 diabetes (24) . Further testing is required for all of these hypotheses.
Given that there is an increasing incidence of type 1 diabetes in Colorado youth (2), our findings support the hypothesis that environmental pressures may be increasing the disease penetrance despite a shift in the distribution of HLA genotypes from high to moderate-low risk. Although this and previous studies (6 -9) evaluating the distribution and frequency of HLA susceptibility genes over time have provided evidence in support of this hypothesis, the nature of environmental factors responsible for the increasing incidence of type 1 diabetes remains unknown.
